The total number of cancer screenings for women declined over 80% in April 2020 compared to the previous five Aprils. That's according to the Centers for Disease Control (CDC).
The CDC says the prolonged delays in screenings for breast and cervical cancer related to the Covid-19 pandemic may lead to delayed diagnoses and poorer outcomes.
This negative impact is likely to be more pronounced among women already experiencing "health inequities," says the CDC.
This study highlights a decline in cancer screening among women of racial and ethnic minority groups with low incomes when their access to medical services decreased at the beginning of the pandemicAmy DeGroff, PhD, MPH, CDC health scientist and lead author of Covid-19 impact on screenings study
It's unclear why the lowest income women appear to be least likely to get regular cancer screenings since the poor receive free health care, and in general, routine female-related screenings are of no additional cost beyond the premium for those who are insured.
Click the link below to read the CDC press release: